U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN ... As a result, the S&P 500 experienced a significant drop, and European markets also closed lower. Today, Richard Fisher ...

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz ...

Amgen and Ideaya Biosciences are winding down their cancer combination study, closing off one way the Big Biotech was looking to dial up the efficacy of its PRMT5 inhibitor AMG 193. The ...

In early February, Amgen released financial results for the 4th quarter of 2024, which I was eagerly awaiting. In addition to demonstrating efficacy in the treatment of nasal polyps in Phase 3 ...